(Q64231976)

2

0 references

Shimpei Anami

3

0 references

Kohei Fukuda

4

0 references

Masahiro Inada

5

0 references

Hitoshi Tatebe

6

0 references

Kazuki Ishikawa

7

0 references

Shuichi Kanamori

8

0 references

Hajime Monzen

9

0 references

Yasumasa Nishimura

Suppression of lymphokine-activated killer induction by neutrophils

10

0 references

language of work or name

0 references

0 references

33

0 references

issue

1

0 references

page(s)

195-201

0 references

cites work

1 reference

12 December 2020

Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials

1 reference

12 December 2020

Incidence Proportions of Brain Metastases in Patients Diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System

1 reference

12 December 2020

A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database.

1 reference

12 December 2020

Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer

1 reference

12 December 2020

1 reference

12 December 2020

Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer

1 reference

12 December 2020

Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline

1 reference

12 December 2020

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer

1 reference

12 December 2020

Targeted Therapy for Brain Metastases in EGFR-Mutated and ALK-Rearranged Non-Small-Cell Lung Cancer

1 reference

12 December 2020

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

1 reference

12 December 2020

Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferio

1 reference

12 December 2020

Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial.

1 reference

12 December 2020

Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.

1 reference

12 December 2020

PD-L1 expression in lung cancer and its correlation with driver mutations: a meta-analysis

1 reference

12 December 2020

Excellent Outcomes with Radiosurgery for Multiple Brain Metastases in Oncogene-Addicted Non-Small-Cell Lung Cancer.

1 reference

12 December 2020